Clinical trials
Phase 3 Macular Degeneration trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 3 |
| 2009 | 1 |
| 2016 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 17 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Eye Institute (NEI) | 3 |
| Shahid Beheshti University of Medical Sciences | 2 |
| AO GENERIUM | 1 |
| Instituto de Olhos de Goiania | 1 |
| Klinikum Bremen-Mitte, gGmbH | 1 |
| Klinikum Ludwigshafen | 1 |
| Luye Pharma Group Ltd. | 1 |
| Miravant Pharmaceuticals | 1 |
| NeoVista | 1 |
| OccuLogix | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Macular Degeneration | 17 |
| Choroidal Neovascularization | 2 |
| Cataract | 1 |
| Histoplasmosis | 1 |
| Vision Disorders | 1 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.